Role of EGFR inhibitors in the treatment of central nervous system metastases from non-small cell lung cancer
GL Ceresoli - Current Cancer Drug Targets, 2012 - ingentaconnect.com
Brain metastases (BM) are a common occurrence in patients with non-small cell lung cancer
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …
Role of EGFR inhibitors in the treatment of central nervous system metastases from non-small cell lung cancer
GL Ceresoli - Current cancer drug targets, 2012 - pubmed.ncbi.nlm.nih.gov
Brain metastases (BM) are a common occurrence in patients with non-small cell lung cancer
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …
Role of EGFR inhibitors in the treatment of central nervous system metastases from non-small cell lung cancer.
GL Ceresoli - Current Cancer Drug Targets, 2012 - europepmc.org
Brain metastases (BM) are a common occurrence in patients with non-small cell lung cancer
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …
(NSCLC). Standard therapy options include whole brain radiotherapy and, in selected …